MT921
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MT921, covering 2020-07-29 to 2023-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat [Phase 3]